OKYO PHARMA LTD SP.ADR/65 (OK10) — Cash Flow-to-Debt Ratio
Latest as of March 2025:
-0.20x
OKYO PHARMA LTD SP.ADR/65 (OK10) has a Cash Flow-to-Debt Ratio of -0.20x as of March 2025, meaning its operating cash flow of €-1.81 Million could theoretically repay 0% of its total liabilities (€9.23 Million) in one year. See OKYO PHARMA LTD SP.ADR/65 free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.20x
Operating CF / Total Liabilities
Operating Cash Flow
€-1.81 Million
EUR
Total Liabilities
€9.23 Million
EUR
Data as of
Mar 2025
Most recent filing
OKYO PHARMA LTD SP.ADR/65 Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for OKYO PHARMA LTD SP.ADR/65 across 4 annual periods. For the full cash flow conversion analysis, see OK10 cash flow metrics.
Annual Cash Flow-to-Debt Ratio for OKYO PHARMA LTD SP.ADR/65 (2022–2025)
Year-by-year debt coverage analysis for OKYO PHARMA LTD SP.ADR/65.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.20x | €-1.81 Million | €9.23 Million | ▲ +84.7% |
| 2024 | -1.28x | €-9.49 Million | €7.42 Million | ▼ -20.6% |
| 2023 | -1.06x | €-7.70 Million | €7.26 Million | ▲ +73.8% |
| 2022 | -4.04x | €-5.47 Million | €1.35 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.